Scinai Immunotherapeutics Ltd. (SCNI)
SCNI trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.23
+6.03% on the day
Market cap
$1.7M
Nano cap
Revenue · 2025
$1.3M
+99.2% on 2024
Net income · 2025
-$8.3M
-633.6% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | SCNI on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | Israel |
| IPO year | 2015 |
| SEC CIK | 0001611747 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | L3 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.3M |
| Net income | -$8.3M |
| Operating income | -$7.5M |
| Net margin | -633.6% |
| Operating margin | -575.3% |
| Revenue growth | +99.2% |
| Cash | $1.7M |
| Total assets | $11.6M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.3× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document REGISTRATION STATEMENT | F-1 | 2026-09-24 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-04-01 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-10-13 |
| Latest current report CURRENT REPORT | 8-K | 2023-06-08 |
Source: SEC EDGAR submissions feed, 491 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CRIS | Curis Inc. | $0.6149 | -4.42% | $1.3M |
| HLSQ | Tessera Defense and Homeland Security Inc. | $0.2600 | -7.08% | $2.3M |
| SLXN | Silexion Therapeutics Corp | $0.1760 | -1.24% | $2.5M |
| VIVS | VivoSim Labs Inc. | $0.1742 | +0.12% | $2.9M |
| CLDI | Calidi Biotherapeutics Inc. | $0.8999 | -5.26% | $3.3M |
| PMCB | PharmaCyte Biotech Inc. | $0.3559 | -2.52% | $3.8M |
| LIMN | Liminatus Pharma Inc. | $3.41 | -1.16% | $4.6M |
| SCLXW | Scilex Holding Company Warrant | $0.0621 | -14.35% | $527K |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier